Skip to main content
. 2020 Aug 31;14:734. doi: 10.3389/fnins.2020.00734

Figure 1.

Figure 1

(A) Selection diagram depicting the number of studies included for the spectrum of studied neurodegenerative diseases; and (B) PRISMA flowchart.